Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Raab

Showing results (11-20 of 426) with videos related to

Pageof 43
Sort By:
Blood|February 25, 2017
Oxygen bubbles to predict sensitivity to IMiDsMarc S Raab
Archives of Pathology & Laboratory Medicine|July 23, 2003
Human papillomavirus reporting: impact on Bethesda cytology reportsStephen S Raab
Clinics in Laboratory Medicine|November 24, 2004
Improving patient safety by examining pathology errorsStephen S Raab
Archives of Pathology & Laboratory Medicine|May 11, 2006
Improving patient safety through quality assuranceStephen S Raab
Blood|January 4, 2024
Venetoclax in myeloma: to B, or not to BMarc S Raab
Diagnostic Cytopathology|February 3, 2004
Factors affecting the adoption of new cytology technologiesStephen S Raab
Clinics in Laboratory Medicine|November 26, 1999
Cost-effectiveness analysis in pathologyS S Raab
Archives of Pathology & Laboratory Medicine|August 3, 2000
The cost-effectiveness of immunohistochemistryS S Raab
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association|February 6, 1998
The utility and cost-effectiveness of Pap test rescreeningS S Raab
American Journal of Clinical Pathology|September 5, 1998
The cost-effectiveness of routine histologic examinationS S Raab
Pageof 43

Showing results (11-20 of 426) with videos related to

Sort By:
Pageof 43
Blood|February 25, 2017
Oxygen bubbles to predict sensitivity to IMiDsMarc S Raab
Archives of Pathology & Laboratory Medicine|July 23, 2003
Human papillomavirus reporting: impact on Bethesda cytology reportsStephen S Raab
Clinics in Laboratory Medicine|November 24, 2004
Improving patient safety by examining pathology errorsStephen S Raab
Archives of Pathology & Laboratory Medicine|May 11, 2006
Improving patient safety through quality assuranceStephen S Raab
Blood|January 4, 2024
Venetoclax in myeloma: to B, or not to BMarc S Raab
Diagnostic Cytopathology|February 3, 2004
Factors affecting the adoption of new cytology technologiesStephen S Raab
Clinics in Laboratory Medicine|November 26, 1999
Cost-effectiveness analysis in pathologyS S Raab
Archives of Pathology & Laboratory Medicine|August 3, 2000
The cost-effectiveness of immunohistochemistryS S Raab
Clinical Laboratory Management Review : Official Publication of the Clinical Laboratory Management Association|February 6, 1998
The utility and cost-effectiveness of Pap test rescreeningS S Raab
American Journal of Clinical Pathology|September 5, 1998
The cost-effectiveness of routine histologic examinationS S Raab
Pageof 43